Repurposing bunamidine hydrochloride as a potent antimicrobial agent targeting vancomycin-resistant Enterococcus membranes
mSystems · 2025
DOI: 10.1128/msystems.00425-25 ↗Kurz gefasst
Fachartikel in der Zeitschrift mSystems, 2025. Verfasst von Pengfei She und 10 weiteren Autor:innen. Beteiligte Einrichtung: Department of Laboratory Medicine, The Third Xiangya Hospital of Central South University, Changsha, Hunan, China. Hauptthemen laut MEDLINE: Vancomycin-Resistant Enterococci, Drug Repositioning, Anti-Bacterial Agents, Cell Membrane. Die Arbeit nennt 71 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: National Natural Science Foundation of China, Natural Science Foundation of Hunan Province.
Abstract (Originalsprache)
Vancomycin-resistant enterococci (VRE) are a major cause of hospital-acquired infections, with limited treatment options due to rising antibiotic resistance. Targeting bacterial membranes offers a promising alternative to conventional therapies. In this study, we investigated the antimicrobial activity and mechanism of action of bunamidine hydrochloride (BUN) against VRE. BUN exhibited potent bactericidal effects against both VRE and vancomycin-susceptible enterococci (VSE), with minimum inhibitory concentrations (MICs) ranging from 2 to 4 µg/mL. BUN significantly inhibited biofilm formation and eradicated biofilm-embedded persister cells. Mechanistic studies demonstrated that BUN disrupts bacterial membrane integrity, increasing permeability and depolarization, as confirmed by SYTOX Green staining, DiSC3(5) fluorescence analysis, and electron microscopy. Molecular dynamics simulations further revealed that BUN selectively interacts with phosphatidylglycerol, a key bacterial membrane phospholipid, leading to membrane destabilization. In vivo studies using murine infection models showed that BUN effectively reduced bacterial burden and promoted wound healing without notable toxicity. These findings highlight BUN as a promising antimicrobial agent with membrane-targeting activity against VRE. Its potent bactericidal action, low propensity for resistance development, and favorable in vivo efficacy suggest potential for therapeutic application in treating multidrug-resistant infections. IMPORTANCE The global rise of vancomycin-resistant enterococci (VRE) poses serious challenges in clinical treatment due to limited therapeutic options and rapid resistance development. This study identifies bunamidine hydrochloride (BUN), a previously approved antiparasitic agent, as a potent membrane-targeting antimicrobial with rapid bactericidal activity against both planktonic and biofilm-associated VRE. By selectively interacting with bacterial phosphatidylglycerol, BUN disrupts membrane integrity and inhibits persister cells, while maintaining low cytotoxicity and high in vivo efficacy in murine infection models. Our findings highlight the potential of drug repurposing strategies to accelerate the discovery of effective antibiotics and provide a promising candidate for future clinical management of multidrug-resistant bacterial infections.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Laboratory Medicine, The Third Xiangya Hospital of Central South University, Changsha, Hunan, China.
- Department of Laboratory Medicine, The Affiliated Changsha Hospital of Xiangya School of Medicine (The First Hospital of Changsha), Central South University, Changsha, Hunan, China.
ORCID-Profile: Yong Wu
Förderung
- National Natural Science Foundation of China
- Natural Science Foundation of Hunan Province
Zitieren
APA
She, P., Huang, G., Guo, S., Xiao, D., Liu, Y., Li, M., Lu, L., Hong, Y., Li, Y., Zhou, L., & Wu, Y. (2025). Repurposing bunamidine hydrochloride as a potent antimicrobial agent targeting vancomycin-resistant Enterococcus membranes. mSystems. https://doi.org/10.1128/msystems.00425-25
Vancouver
She P, Huang G, Guo S, Xiao D, Liu Y, Li M, et al. Repurposing bunamidine hydrochloride as a potent antimicrobial agent targeting vancomycin-resistant Enterococcus membranes. mSystems. 2025. doi:10.1128/msystems.00425-25
BibTeX
@article{She2025,
author = {She, Pengfei and Huang, Guanqing and Guo, Shaowei and Xiao, Dan and Liu, Yiqing and Li, Mengna and Lu, Lihua and Hong, Yelan and Li, Yimin and Zhou, Linying and Wu, Yong},
title = {Repurposing bunamidine hydrochloride as a potent antimicrobial agent targeting vancomycin-resistant Enterococcus membranes},
journal = {mSystems},
year = {2025},
doi = {10.1128/msystems.00425-25}
}
EUVIMED